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Kaposi's Sarcoma-associated herpesvirus encodes a homolog of the human cellular interleukin-6 that may play a formative role in many
KSHV-related diseases. While the viral IL-6 can signal similarly to its human counterpart little is known about the role of vIL-6 during KSHV
infection. Using homologous recombination and selection in eukaryotic cells, a KSHV isolate was purified that does not express vIL-6 as was a
control recombinant that left vIL-6 intact. The two viruses establish and maintain latency to similar levels in BJAB B-cells, reactivate to similar
levels in B-cells and Monkey kidney cells and have very similar KSHV gene expression patterns. BJAB cells expressing KSHV survive better
than the parental BJAB cells in low serum and the vIL-6 deletion does not abrogate this growth advantage. Thus vIL-6 is not essential for
establishment, maintenance, or reactivation from latency in cell culture and is not involved in the survival of infected BJAB B-cells in low serum.
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Cytokine dysregulation has been proposed to play a role in
Kaposi's Sarcoma (KS), primary effusion lymphomas (PELs),
and plasmablastic multicentric castleman's disease (pMCD), all
Kaposi's Sarcoma-associated herpesvirus (KSHV)-related dis-
eases. In particular, IL-6 activation is a prominent feature of all
diseases and this dysregulation has been proposed to play a
major role in genesis of these proliferative disorders. Intrigu-
ingly, KSHV encodes a homolog of human IL-6, called vIL-6,
that may play a role in KSHV infection and replication, in
immune evasion and in tumor induction and angiogenesis
(Moore et al., 1996; Neipel et al., 1997; Nicholas et al., 1997).
KSHV vIL-6 has nearly 25% amino acid identity with its human
counterpart and is a necessary autocrine cytokine for primary
effusion lymphoma cells (Jones et al., 1999). When an antibody
that blocked signaling of vIL-6 was employed, low-density PEL
cells did not divide to similar levels as control treated cells.
Thus vIL-6 has been shown to play a role in at least one KSHV-
related B-cell malignancy (Jones et al., 1999).⁎ Corresponding author.
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doi:10.1016/j.virol.2006.09.044The KSHV vIL-6 activates the same downstream signaling
pathways as human IL-6 but it can differ from human IL-6 in its
receptor usage (Hideshima et al., 2000; Molden et al., 1997;
Moore et al., 1996; Osborne et al., 1999). Both human and
KSHV IL-6 activate signaling through the JAK/STAT pathway,
specifically activating STAT3 transcriptional activity (Molden
et al., 1997; Osborne et al., 1999). To activate signaling in a cell,
human IL-6 requires gp130, a surface receptor common to many
cytokines, and gp80, an IL-6 specific component. vIL-6 also
uses the gp130–gp80 combination but does not have the same
absolute requirement for the gp80 moiety (Boulanger et al.,
2004; Li et al., 2001). This makes the viral IL-6 a more
promiscuous activator of signaling since gp130 is present on
many cell types while gp80 is limited to specific cells (Taga and
Kishimoto, 1997). In addition, expression of vIL-6 in transgenic
mice led to increased vascular endothelial growth factor
(VEGF) secretion and new blood vessel formation (Aoki
et al., 1999), indicating a potential role of vIL-6 in angiogenesis
and the development of KSHV-related disorders.
There is differential expression of vIL-6 in different diseases
(Cannon et al., 1999; Moore et al., 1996; Staskus et al., 1999).
In KS tumors vIL-6 is expressed predominantly in the low
percentage of cells undergoing lytic replication and there is little
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likely expressed predominantly during lytic replication (Molden
et al., 1997; Moore et al., 1996; Parravinci et al., 1997; Staskus
et al., 1999). vIL-6 is expressed in a greater proportion of
infected cells in MCD lesions but also tracks with the large
percentage of cells undergoing lytic replication (Brousset et al.,
2001; Staskus et al., 1999). In cultured PEL cells, vIL-6 behaves
as an early lytic gene that is directly induced by the KSHV lytic
switch protein, Rta (Song et al., 2003; Sun et al., 1999). In
uninduced PEL cells, there are low levels of expression, likely
due to the low percentage of cells undergoing lytic replication.
Upon induction with phorbol esters or with sodium butyrate,
vIL-6 expression is strongly induced with early gene kinetics
and is not inhibited by Cidofovir, an inhibitor of herpesvirus
replication (Lu et al., 2004; Nicholas et al., 1997). However, one
study that stained a single PEL in vivo found that a large
proportion of the infected cells expressed variable levels of vIL-
6, indicating the possibility that in vivo, PELs express vIL-6 to
low levels during latency (Staskus et al., 1999). Of relevance to
this finding, upon stimulation of BCP-1 cells, a KSHV positive,
EBV negative PEL line, vIL-6 expression is activated by type I
interferons in the absence of other lytic gene expression
(Chatterjee et al., 2002). However, this activation was not seen
in all PEL lines (Pozharskaya et al., 2004). In addition, the
presence of vIL-6 messenger RNA in KSHV virions (Bechtel et
al., 2005) may provide immediate expression upon viral entry
that could help create a cellular environment optimal for KSHV
establishment of infection. Despite a plethora of data about the
signaling activities and gene expression of vIL-6, little is known
about its role during KSHV infection.
In this study, a vIL-6 deletion mutant was created by
homologous recombination in BCBL-1 cells and purified in
Vero African green monkey kidney cells. In addition, a re-
combinant was created with the selection markers inserted at the
same site as the deletion but with the vIL-6 gene and promoter
left intact to serve as a control for the insertion of the selectable
markers at that site in the genome. Since B-cells are resistant to
infection in culture, we utilized our previously characterized
system to examine KSHV in BJAB cells (Chen and Lagunoff,
2005). ΔvIL-6 and the control virus established latency at
similar levels. vIL-6 was also found to be non-essential for
KSHV reactivation and lytic replication as both viruses
reactivated and produced virus to similar levels in both BJAB
cells and Vero cells. The deletion of vIL-6 did not disrupt KSHV
lytic or latent gene expression, indicating that vIL-6 is not
significantly involved KSHV gene regulation. Furthermore, we
show that KSHV imparted a survival advantage to BJAB cells
grown in low serum but there was no loss of growth advantage in
the ΔvIL-6 virus infected cells. Thus, vIL-6 is non-essential for
KSHV maintenance or replication in cell culture.
Results
Purification of a vIL-6 deletion mutant
In order to determine the potential functions of viral
interleukin 6 (vIL-6) in KSHV replication and pathogenesis,we created a control recombinant KSHV, KSHV-GFP1 (Chen
and Lagunoff, 2005), and a vIL-6 deletion mutant (Fig. 1A). To
create the vIL-6 deletion mutant, part of the open reading frame
K2 gene, spanning between BC-1 positions 17089 and 17563
(Russo et al., 1996), was deleted and re-ligated with a poly-linker
as described in Materials and Methods. Both KSHV-GFP1
recombinant virus and vIL-6 deletion mutants express a GFP-
puromycin resistance fusion protein inserted at the same position
in the KSHV genome. The GFP-puro marker was inserted into a
SpeI site (BC-1 position nt 17089) between the polyadenylation
signals of ORF11 and ORFK2 to avoid potential promoter
interference effects. The control plasmid containing just the in-
sertion or the ΔvIL-6 plasmid were electroporated into BCBL-1
cells and selected for puromycin resistance. The resulting
BCBL-1 cell lines were induced with TPA and virus from the
supernatant was used to infect Vero cells at a low multiplicity of
infection to decrease the chance that multiple virus particles
enter each cell. After selection, puromycin-resistant and GFP-
expressing Vero cell lines were established. The resulting green
Vero cells were then induced with Adeno-50 recombinant virus
and sodium butyrate and the supernatant was used to infect a new
batch of Vero cells at a lowmultiplicity of infection as previously
described (Chen and Lagunoff, 2005; Vieira and O'Hearn,
2004). After at least five rounds of infection, selection, and
purification, Vero cells harboring control recombinant virus,
KSHV-GFP1, or vIL-6 deletion mutant, ΔvIL-6, were estab-
lished. To demonstrate that vIL-6 was deleted from the viral
genome, virion DNA from induced Vero cells containing the
control or ΔvIL-6 virus was isolated, digested, and subjected to
Southern blot analysis. As seen in Fig. 1B, probe P1 recognizing
the vIL-6 region deleted recognizes a slightly slower-migrating
species in the KSHV-GFP1 lane, indicative of the insertion of
GFP-puro marker, but not in the ΔvIL-6 lane, indicative of the
deletion of vIL-6. A slightly faster-migrating species is
recognized by probe P2 that recognizes the remaining region
of vIL-6 and full-length ORF2 in the ΔvIL-6 lane due to the
insertion of an additional HindIII site in the poly-linker. The
ΔvIL-6 virus is essentially pure while there is a miniscule
amount of wild type virus seen with the control virus (Fig. 1B).
To confirm the purity of theΔvIL-6, recombinant PCRwith vIL-
6 primers was used. After more than 25 cycles of PCR, no wild
type band could be detected in DNA from ΔvIL-6 virus while it
was easily detected in wild type and the control recombinant
virus. As vIL-6 is a cytokine that can act in a paracrine fashion, it
is critical for the ΔvIL-6 virus to be pure.
To demonstrate that the ΔvIL-6 virus does not express even
the small portion of vIL-6 that was left in the genome, northern
blot analysis was used to examine expression of vIL-6.
Polyadenylated RNA was isolated from the established Vero
cells and was subjected to Northern blot analysis. As seen in
Fig. 1C, vIL-6 was easily detected in the Vero cells harboring
control recombinant virus and BCBL-1 cells following lytic
induction, but not in the Vero cells harboring vIL-6 deletion
mutant. PAN RNA is strongly induced in the control and the
ΔvIL-6 cells indicating that it is the lack of vIL-6 sequences not
the loss of inducibility in selected cells leading to the lack of vIL-
6 mRNA (Fig. 1C). The absence of T1.1 transcript in uninduced
Fig. 1. Creation of theΔvIL-6 recombinant virus. (A) Strategy for generation of theΔvIL-6 recombinant virus. The structure of the first 30 kb of the KSHV genome is
shown at the top. Viral genes are indicated as open boxes. Most of the vIL-6 gene was deleted as described in the Materials and methods. Genomic structure of the
resulting reconstituted KSHV-GFP1 andΔvIL-6 is shown. (B) Southern blot analysis of virion DNA isolated from the supernatants of induced BCBL-1 cells and Vero
cells infected with KSHV-GFP1 orΔvIL-6. The probes used are shown in panel A. Probe P1 corresponds to the vIL-6 region deleted (BC-1 positions 17089 to 17563).
Probe P2 corresponds to the remaining genomic region of vIL-6 and full length of ORF2. (C) Northern blot analysis of uninduced and induced KSHV-GFP1 Vero cells
and ΔvIL-6 Vero cells. BCBL-1 cells and Vero cells infected with KSHV-GFP1 or ΔvIL-6 recombinant viruses were induced with Adeno-50 virus and sodium
butyrate. Forty-eight hours post induction, mRNAwas extracted and analyzed. The Northern blot was probed with radiolabeled sequences containing viral IL-6, PAN
RNA and GAPDH, respectively. U: uninduced. I: induced with Adeno-50 virus and sodium butyrate.
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virus, but not in uninduced BCBL-1 cells, correlates with the low
spontaneous lytic reactivation rate in BJAB cells, which has
been described previously (Chen and Lagunoff, 2005).
vIL-6 is not essential for establishment and maintenance of
KSHV latency in BJAB cells
vIL-6 was shown to be an autocrine growth factor of
lymphoma cells infected with KSHV (Jones et al., 1999).
Therefore we wanted to examine the phenotype of the vIL-6
deletion in B-cells. However, to date B-cells in culture have been
resistant to KSHV infection (Bechtel et al., 2003; Blackbourn et
al., 2000; Renne et al., 1998). In a previous study, we showed
that once KSHV DNA was introduced into B-cells, the virus
could establish andmaintain latency (Chen and Lagunoff, 2005).
To determine the role of vIL-6 in KSHV replication, episomal
KSHV DNA from the control recombinant or ΔvIL-6 was
introduced into BJAB cells as previously described (Chen and
Lagunoff, 2005). Forty-eight hours after electroporation, GFP
expression was observed. After 2 weeks under selection, nearly
100% of the BJAB cells expressed GFP and reacted with the
LANA antibody, showing the typical speckled pattern (Fig. 2A),
which indicates that both KSHV-GFP1 andΔvIL-6 recombinant
virus established latency in an equivalent time period and asimilar number of cells grew out of selection. In addition, similar
numbers of LANA speckles were seen in BJAB cells containing
KSHV-GFP1 or ΔvIL-6 recombinant viruses indicating that
they contained similar numbers of episomal copies (L. Chen and
M. Lagunoff, data not shown). Thus vIL-6 is not essential for the
establishment of KSHV latency in BJAB cells.
Similar to TIME cells and other cell types, the KSHV latent
episome is lost in a significant percentage of BJAB cells over
the course of one month (Chen and Lagunoff, 2005; Grundhoff
and Ganem, 2004; Lagunoff et al., 2002). As seen in Fig. 2B,
after 1 month in culture in the presence of puromycin selection,
approximately 85% of the cells are still GFP positive and react
with LANA antibody. After 1 month in culture without
puromycin selection, approximately 50% of the cells remain
GFP positive and express LANA. Over the time course of 1
month, the control recombinant virus and the vIL-6 deletion
mutant are lost at a similar rate. Thus vIL-6 is not essential for
the maintenance of KSHV latent episomes in BJAB cells.
Interestingly, both control recombinant virus and vIL-6 deletion
mutant are maintained in a small percentage of cells over the
course of 5 months in the absence of puromycin selection
(L. Chen and M. Lagunoff, data not shown).
To demonstrate that the vIL-6 deletion mutant indeed
established and maintained latency in BJAB cells and did not
integrate into the host genome, cell samples infected with
Fig. 2. vIL-6 is not essential for the establishment and maintenance of KSHV latency. (A) Photomicrographs of BJAB cells infected with KSHV-GFP1 or ΔvIL-6,
showing 4′,6′-diamidino-2-phenylindole (DAPI) (left panel), GFP fluorescence (middle panel), and LANA red fluorescence (right panel). (B) The KSHV latent
episome was gradually lost in BJAB cells. The percentage of LANA positive cells at each time-point is shown. Each value represents the average of three separate
experiments at each time-point. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
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analysis as previously described (Chen and Lagunoff, 2005). As
seen in Fig. 3, in uninduced BJAB cells harboring control
recombinant virus and BJAB cells harboring ΔvIL-6, the
predominant species that reacts with KSHV sequences migrates
similarly to episomal virus from BCBL-1 cells and much slower
than KSHV virion DNA. Thus both control recombinant virus
and ΔvIL-6 are maintained in an episomal form in BJAB cells.
Due to a low percentage of spontaneously lytic reactivation,
significant amounts of linear KSHV DNA are detected in
uninduced BCBL-1 cells. There is no detectable linear or
circular KSHV DNA in uninfected BJAB cells (Fig. 3). This has
been repeated at different occasions with cells of different
passage numbers and similar results were observed.
vIL-6 is not essential for KSHV lytic reactivation from latency
in BJAB cells
The Control recombinant virus was previously shown to be
able to reactivate in BJAB cells (Chen and Lagunoff, 2005). Todetermine if vIL-6 is involved in KSHV lytic reactivation from
latency in BJAB cells, BJAB cells harboring control recombi-
nant virus and BJAB cells harboring ΔvIL-6 were induced and
subjected to Gardella gel analysis. Similar amounts of linear
KSHV DNA are detected in induced BJAB cells harboring
control recombinant virus and in BJAB cells harboring ΔvIL-6
(Fig. 3). The low amount of linear KSHV DNA detected
corresponds to the low percentage of lytic reactivation in BJAB
cells. To accurately measure and compare the percentage of lytic
reactivation in BJAB cells, BJAB cells harboring control
recombinant virus orΔvIL-6 were induced with Adeno-50 virus
and sodium butyrate and subjected to flow cytometric analysis
as previously described (Lagunoff et al., 2001). Recombinant
KSHV containing BJAB cells were induced for 24 h and the
number of cells expressing ORF 59, a marker of lytic
replication, was determined by flow cytometry. As seen in
Fig. 4, we performed the experiment with 3 separate cell lines
created on 3 different occasions for the control virus, KSHV-
GFP1 and forΔvIL-6. The average rate of lytic induction for the
KSHV-GFP1 containing cell lines was 1.36%, while in the
Fig. 3. KSHV is episomal in ΔvIL-6 cells. BCBL-1, KSHV-GFP1-BJAB, and
ΔvIL-6-BJAB cells were induced with Adeno-50 (Ad50) and 2 mM sodium
butyrate (NaB). Forty-eight hours after induction, uninduced and induced cells
were examined by Gardella gel electrophoresis to detect KSHV episomes.
KSHV virion was used as a control. 32P-labeled KSHV genomic region
spanning ORFK2 and ORF2 was used as a probe. U: uninduced. I: induced with
Adeno-50 virus and sodium butyrate.
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difference in reactivation (Fig. 4).
To further demonstrate that the ΔvIL-6 virus can be induced
to undergo lytic replication cycle, Vero cells harboring control
recombinant virus or ΔvIL-6 were induced with Adeno-50
recombinant virus and sodium butyrate. Forty-eight hours post
induction, immunofluorescence assay was performed with the
ORF59 antibody. As seen in Fig. 5, no significant difference in
lytic reactivation rates was observed between control recombi-
nant virus andΔvIL-6. The percentage of ORF59 positive cells,
indicative of lytic KSHV replication, was 10.8% and 8.5%,
respectively. To demonstrate that ΔvIL-6 can complete the
entire lytic cycle and produce infectious virus, infection assays
were done with induced supernatants. Seventy-two hours after
induction of KSHV-GFP1 and ΔvIL-6 Vero cells, the super-
natant of each sample was harvested and was used to infect a
fresh batch of Vero cells. Viral infection rates were determined
by counting the number of cells expressing GFP, indicative of
recombinant virus infection. No GFP expression is detected
when virus harvested from uninduced KSHV-GFP1 Vero cells
or ΔvIL-6 Vero cells is used as the inoculum. Virus harvested
from supernatants of KSHV-GFP1 Vero cells induced with
Adeno-50 virus and sodium butyrate yields on average 3200
GFP-positive cells per 25×106 cells induced, while virus
isolated from supernatants of ΔvIL-6 Vero cells induced with
same reagents yields on average 2840 GFP-expressing cells per25×106 cells induced (numbers are the average of three
separate experiments).
Deletion of vIL-6 does not disrupt KSHV gene expression
To determine if the deletion of vIL-6 disrupts overall viral
gene expression, a viral DNA array was established to measure
the expression level of representative latent, immediate-early,
early, and late genes. The quality of the spotting of the PCR
based array was first confirmed with total KSHV DNA.
Polyadenylated RNAwas isolated from uninduced and induced
BCBL-1 cells and BJAB cells harboring control recombinant
virus or ΔvIL-6. Polyadenylated RNA was then reverse
transcribed, labeled with 32P, and subjected to viral DNA array
assay as described in Materials and methods. As seen in Fig. 6,
both control recombinant virus andΔvIL-6 shared similar latent,
immediate-early, early, and late gene expression patterns with
their parental BCBL-1 virus. The expression level of major
latent transcripts including LANA, viral FLIP, and viral cyclin is
not strongly increased upon induction while the Kaposin
transcript is greatly increased (Fig. 6A). Lytic gene expression
is greatly increased following TPA or Adeno-50 virus treatment
of all cell types (Figs. 6B–D). In comparison to that in BCBL-1
cells, the lower level of immediate-early, early, and late viral
gene expression in BJAB cells harboring KSHV-GFP1 and
ΔvIL-6 is consistent with the lower lytic spontaneous and
induced reactivation rate in induced BJAB cells infected with
control recombinant virus orΔvIL-6. Thus, the deletion of vIL-6
does not disrupt viral gene expression during latent or lytic
replication cycles. Data shown here (Fig. 6) are representative of
three experiments repeated on different occasions.
Both control recombinant virus and wild type KSHV isolated
from induced BCBL-1 cells share similar ORF11 and ORF2
gene expression patterns, which indicates that the insertion of
GFP-puromycin resistance marker into the SpeI site (BC-1
position nt 17089) did not interfere with flanking viral promoter
activities. This is expected as the GFP-puromycin resistance
marker was inserted between the polyadenylation signals of
ORF11 and ORFK2. However, the deletion of vIL-6 leads to the
higher expression of ORF11 expression in uninduced ΔvIL-6
infected cells (L. Chen and M. Lagunoff, data not shown),
which indicates that the vIL-6 region deleted (BC-1 positions
17089 to 17563) may be involved in the regulation of ORF11
expression in the lytic cascade. The exact function of ORF11 is
still unknown; however, our data suggest that the deregulation
of ORF11 expression is not critical for either latent or lytic
KSHV replication.
The presence of vIL-6 does not account for the survival
advantage of KSHV infected BJAB cells in low serum
The inhibition of vIL-6 signaling by dominant-negative
STAT3 expression induced apoptosis in primary effusion
lymphoma cells (Aoki et al., 2003). To determine the role of
vIL-6 in BJAB cell growth in the context of KSHV infection,
live cells were measured by trypan-blue staining. Methyl
thiazolyl tetrazolium (MTT) assay was also performed as
Fig. 4. Evaluation of Lytic reactivation of KSHV-GFP1 and ΔvIL-6 recombinant KSHV in BJAB cells. BJAB cells containing KSHV-GFP1 or ΔvIL-6 were induced
with Adeno-50 recombinant virus and 3 mM sodium butyrate. Cells were fixed and stained for flow cytometry 24 h after induction. The top panel lists the percentage of
live cells expressing ORF 59. The bottom panel shows an example of the primary flow cytometry data. The x axis is set for GFP detection, while the y axis is set for
ORF59 antibody conjugated to phycoerythrin. The gate shown was based on negative and positive controls, and applied to all samples.
Fig. 5. Photomicrographs of uninduced and induced KSHV-GFP1 Vero cells and ΔvIL-6 Vero cells. Top panels shows nuclear staining (4′,6′-diamidino-2-
phenylindole or DAPI), and lower panels show ORF59 fluorescence in red. Vero cells (leftmost panels) were included as negative control. Quantification is described
in the text. U: uninduced. I: induced with Adeno-50 virus and sodium butyrate. (For interpretation of the references to colour in this figure legend, the reader is referred
to the web version of this article.)
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Fig. 6. vIL-6 deletion does not disrupt KSHV gene expression patterns. KSHV membrane arrays were hybridized with oligo(dT) primed radiolabeled cDNA
synthesized from BCBL-1 cells, KSHV-GFP1 BJAB cells, and ΔvIL-6 BJAB cells at 48 hpi in the absence or presence of induction. U: uninduced. I: induced with
Adeno-50 virus and sodium butyrate. Major latent genes (A), immediate-early genes (B), early genes (C) and late genes (D) were shown. Data shown here are
representative of three experiments repeated on different occasions.
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normal (10%) serum conditions, BJAB cells infected with
KSHV-GFP1 and BJAB cells infected with ΔvIL-6 grow at a
similar rate. In the absence of puromycin selection, both KSHV-
GFP1 and ΔvIL-6 infected BJAB cell lines grow at a slightly
slower rate than their parental BJAB cells. No growth advantage
was observed when vIL-6 was over-expressed in BJAB cells.
The above data were also confirmed by MTT assays.
KSHV-GFP1 infected BJAB cells are more resistant to
serum starvation induced apoptosis than their parental BJAB
cells (Fig. 7B). However, the ΔvIL-6 infected BJAB cells
maintained the same growth advantage as the control virus
indicating that presence of vIL-6 does not impart the growth
advantage to infected BJAB cells. Similar resistance to low
serum induced apoptosis is also observed under 0.1%, 0.5%,
and 2% serum conditions. Thus, a KSHV gene (or genes) other
than vIL-6 is responsible for the resistance of serum starvation
induced apoptosis in BJAB cells. Further investigation is
ongoing to understand which viral gene is responsible for the
resistance and the underlying mechanism.Discussion
The data presented here provide the first analysis of a KSHV
gene knockout created by homologous recombination in
eukaryotic cells and purified by infection of eukaryotic cells.
The function of many KSHV genes has been elucidated by
over-expression of the viral gene in cultured cells or in mice in
the absence of other KSHV gene expression. However, this
method takes the gene out of the context of total KSHV gene
expression and the tight regulation of gene expression exerted
by herpesviruses. The classic method to determine the role of
herpesviral genes during infection is to delete a single gene for
the genome and analyze phenotypic changes during infection
with the deletion recombinant as compared to wild type virus.
While the generation of recombinant KSHV isolates has proved
to be difficult, a couple of systems have recently emerged. A
bacterial artificial chromosome containing the entire KSHV
genome has successfully been used to make recombinant
KSHV isolates (Krishnan et al., 2005; Luna et al., 2004; Xu
et al., 2005; Ye et al., 2004; Zhou et al., 2002), though these
Fig. 7. The presence of vIL-6 does not provide growth advantage to KSHV
infected BJAB cells. Cell counts from Recombinant Infected BJAB cells
growing under normal (10%) serum conditions (A) or under serum starvation
(1%) conditions (B). The average number of live cells at each time-point is
shown. Each value represents the average of three separate experiments at each
time-point. The data were also confirmed by Methyl thiazolyl tetrazolium
(MTT) assay as described in the text.
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BAC sequences. Recently, the Vieira lab (Vieira and O'Hearn,
2004) and we (Chen and Lagunoff, 2005) have showed that
KSHV mutants could be generated by homologous recombina-
tion in PEL cell lines and subsequently be purified in Green
monkey kidney (Vero) cells. While generation of recombinant
viruses is possible, analysis of the recombinant viruses has
proved difficult due to the lack of efficient infection systems. In
particular B-cells in culture are resistant to infection with
KSHV (Bechtel et al., 2003). To analyze the effects of KSHV
infection on B-cells in culture, we overcame the block in
infection by introducing the entire genome of a recombinant
KSHV directly into BJAB cells by electroporation and
selecting for cells containing KSHV containing a selectable
marker. Thus we have circumvented the lack of infection in
culture and can examine recombinant viruses in B-cells in a
controlled fashion (Chen and Lagunoff, 2005). We used this
system to provide a controlled B-cell system to determine the
role of vIL-6 in the context of KSHV infection.Many roles for vIL-6 have been proposed during KSHV
infection and pathogenesis. Since the vIL-6 mRNA is present in
the virion, it was proposed that it might play a role in creating an
environment that promotes KSHV establishment of infection
(Bechtel et al., 2005). It has also been proposed that vIL-6
signaling may play a role in viral replication or viral gene
regulation. The studies presented here demonstrate that if vIL-6
plays any role in KSHV establishment of latency, reactivation,
or lytic replication, it is a relatively minor one or limited to
specific cell types. In addition our studies show that vIL-6 does
not play a role in the regulation of KSHV transcription.
To examine the potential role of vIL-6 in cell proliferation,
we grew BJAB cells infected with the control recombinant or
ΔvIL-6 in low serum conditions. KSHV infection of BJAB cells
provides a significant and reproducible increase in cell number
at multiple time points. We used a number of different KSHV-
BJAB isolates established on different occasions and reprodu-
cibly see a 2-fold increase in cell number when the cells are
grown in low serum conditions. We found an identical growth
curve with the BJAB cells containing the ΔvIL-6 virus
indicating that vIL-6 is not essential for the KSHV induced
protection of BJAB cell from apoptosis induced by serum
starvation. One caveat to this set of experiments is that BJAB
cells are already immortal and do not rely on the presence of
KSHV for growth as PEL cells do. However, to date there is no
system for analyzing these effects in primary B-cells. Our
attempts to eliminate vIL-6 in PEL cells using RNAi lead to a
greater than 50% decrease in vIL-6 (Chen and Lagunoff,
unpublished). However, for a low abundance cytokine, even
low-level expression may allow full signaling and will likely
not be indicative of the function of the gene. Thus the deletion
virus approach is critical. It is very intriguing that KSHV
provides some growth advantage to BJAB cells in restrictive
conditions. Further studies are underway to address this growth
advantage in low serum provided by KSHV.
In the generation of PELs, the infected B-cells have become
reliant on vIL-6 signaling. Our studies show that this reliance
is not due to the role of vIL-6 in KSHV latency or replication
but rather likely play a direct role in the B-cells immortal
growth. The data presented here show that our BJAB cell
system allows for the analysis of KSHV recombinants and that
it allows the determination of the essential nature of a KSHV
gene in culture as well as its effects on viral gene regulation.
However, this cell culture system does not allow the functional
identification of KSHV genes that play a role in immune
evasion or directing angiogenesis. The information that can be
gleaned from cell culture models that exist is an important first
step of elucidating the role of viral genes in the context of
KSHV. Further studies to determine the role of vIL-6 in
altering the host cell are underway.
Materials and methods
Cells and media
BCBL-1 cells were grown as previously described (Renne
et al., 1996). BJAB cells are KSHV- and EBV-negative B-cell
433L. Chen, M. Lagunoff / Virology 359 (2007) 425–435lymphoma cells. BCBL-1 cells and BJAB cells were carried in
RPMI 1640 medium (Gibco) supplemented with 10% fetal
bovine serum, penicillin, streptomycin, glutamine, and β-
mercaptoethanol. TIME cells are hTERT-immortalized dermal
microvascular endothelial cells (Lagunoff et al., 2002). TIME
cells were maintained in an EBM-2 medium bullet kit with
supplements (Cambrex). African green monkey kidney (Vero)
cells were maintained in Dulbecco's modified Eagle's medium
supplemented with 10% fetal bovine serum, penicillin,
streptomycin, and glutamine.
Construction of recombinant KSHV
The constructs and creation of the GFP-puro control
recombinant virus were described earlier (Chen and Lagunoff).
For the construction of the vIL-6 deletion mutant (ΔvIL-6),
pKS11K2 was digested with EcoRI and PstI to drop out 303
bases of the vIL-6 gene, and the resulting fragment was re-
ligated with an EcoRI–BamHI–HindIII–XhoI–PstI polylinker,
creating pKS11ΔK2. pKSGFP and pKS11ΔK2 were then
electroporated into BCBL-1 cells. Twenty-four hours post-
transfection, BCBL-1 cells were selected with puromycin. After
selection for 1 month, all cells expressed GFP and were
puromycin resistant. Recombinant virus was harvested from
these cells as previously described (Lagunoff et al., 2002).
African green monkey kidney (Vero) cells were then infected
with recombinant KSHV. Forty-eight hours post-KSHV infec-
tion, medium was replaced with fresh medium containing 10 μg
of puromycin per milliliter. The culture medium was replaced
with fresh puromycin-containing medium every day to remove
dead cells until green colonies were visible. The purification of
recombinant KSHV virus was done similarly to a previous
description (Vieira and O'Hearn, 2004). Briefly, supernatant
from KSHV-Vero cells induced with a defective Adenovirus
expressing the KSHV ORF 50 gene (a kind gift of Don Ganem)
and 3 mM sodium butyrate were used to infect new Vero cells at
a low multiplicity of infection (MOI). The MOI was determined
empirically by determining the dilution of virus stock that
yielded infection of less than 1% of the cells as determined by
visualization of GFP. Single GFP-expressing colonies were
isolated with a cloning cylinder. Each colony was tested for the
purity of recombinant virus by PCR and/or Southern analysis.
Vero cells carrying a higher percentage of recombinant KSHV
were induced, and supernatant was used to infect new Vero
cells. Single green colonies were isolated and screened. This
procedure was repeated at least five times, and KSHV-Vero and
ΔvIL-6-Vero cell lines were established and used in the
subsequent study.
Viruses and induction
KSHV was harvested as previously described (Lagunoff
et al., 2002). For infections, the viral pellet was resuspended in
the indicated medium and used to inoculate corresponding cell
cultures for 2 h. The cell monolayer was then washed once and
overlaid with fresh complete medium. For Vero cell inductions,
the cell monolayer was infected with Adenovirus recombinantexpressing KSHV ORF50 (Adeno-50) at a density of
approximately 4000 particles per cell for 2 h. The Adenovirus
was pre-incubated with 1 μg/ml polylysine (Sigma) in medium
for 100 min at room temperature (Liang and Ganem, 2003).
After infection, the cell monolayer was washed three times and
overlaid with fresh complete medium containing 3 mM sodium
butyrate. For BJAB cell inductions, cells were pelleted and the
cell pellet was resuspended with 0.5 ml of polylysine-treated
Adeno-50 virus inoculum. Cells were infected with Adeno-50
virus at a density of 4000 to 5000 particles per cell for 2 h. After
infection, the cells were washed three times and resuspended in
fresh complete medium containing 2 mM sodium butyrate.
BCBL-1 cells were induced with phorbol 12-myristate-13-
acetate (PMA) at a final concentration of 20 ng/ml.
BJAB lytic reactivation assay
To quantify the induction rate using Adeno-50 with sodium
butyrate, three different KSHV-GFP1-BJAB andΔvIL-6-BJAB
isolates were performed and the rate of reactivation was
quantified by flow cytometry analysis for ORF 59 as described
before (Lagunoff et al., 2001). KSHV-GFP1-BJAB and ΔvIL-
6-BJAB cells (2×107) growing to log phase were induced with
Adeno-50 virus (4000 particles/cell) and 3 mM sodium
butyrate. Twenty-four hours after induction, cells were washed
in phosphate-buffered saline (PBS); fixed in 1% paraformalde-
hyde; washed in PBS with 1% bovine serum albumin, 0.02%
saponin, and 0.1% sodium azide; incubated with mouse
monoclonal antibody to ORF59 in the PBS-saponin buffer;
washed; incubated with secondary goat anti-mouse phycoery-
thrin antibody; washed; and run on an influx flow cytometer.
Gating on live cells, one laser filter was set to measure GFP
while the other was set for phycoerythrin. BJAB and BCBL-1
cells were used as negative and positive controls respectively.
Episomal DNA preparation and electroporation into BJAB
cells
KSHV episomes were isolated from KSHV-Vero and ΔvIL-
6-Vero cells (5×106) by an alkaline lysis procedure as
previously described (Chen and Lagunoff, 2005; Simpson and
Huxley, 1996). KSHVepisomal DNAwas then transfected into
2×107 BJAB cells via electroporation (Bio-Rad Gene Pulser II;
210 V, 960 μF). Transfected cells were resuspended in 20 ml of
culture medium. At 2 days post-transfection, medium was
replaced with fresh medium containing 10 μg of puromycin per
milliliter. Half of the culture medium was replaced with fresh
puromycin-containing medium every 5 days.
Immunofluorescence assay
Immunofluorescence assays were done as previously
described (Chen and Lagunoff, 2005; Lagunoff et al., 2002).
The primary antibodies used were an anti-LANA peptide rabbit
polyclonal antiserum (a kind gift from A. Polson and D.
Ganem) and mouse monoclonal antibodies that recognize ORF
59 (Advanced Biotechnologies Inc.). The primary antibodies
434 L. Chen, M. Lagunoff / Virology 359 (2007) 425–435were diluted 1:1000, and secondary antibodies – anti-rabbit
Alexa fluor 488 and anti-mouse Alexa fluor 594 (Molecular
Probes) – were diluted 1:1000.
Gardella gel electrophoresis
The Gardella gel assay was performed as previously
described (Gardella et al., 1984). Uninduced and induced
BJAB cells latently infected with KSHV or vIL-6 deletion
mutant were washed twice in phosphate-buffered saline. The
cell pellets (1×106 cells) were resuspended in loading buffer
containing 5% Ficoll and 40 μg/ml RNase A in Tris–borate-
EDTA and then loaded onto the gels. The gels were run at 40 V
for 4 h and then at 120 V for an additional 22 h in Tris–borate–
EDTA at 4 °C. The gels were then dried, rehydrated in 0.5 M
NaOH–0.15 M NaCl buffer, and directly probed with 32P-
radiolabeled DNA corresponding to KSHV sequences.
Southern and Northern blot analyses
Virion DNA was purified from BCBL-1, KSHV-BJAB, and
ΔvIL-6-BJAB cells as previously described (Chen and Lagunoff,
2005). Isolated virion DNA was digested with HindIII and
subjected to Southern blot analysis as previously describe (Chen
and Lagunoff, 2005; Lagunoff and Ganem, 1997). The blot was
probed with 32P-radiolabeled probe P1 and P2, respectively. Total
RNA was extracted from 2.5×107 uninduced and induced
BCBL-1, KSHV-BJAB, or ΔvIL-6-BJAB cells with RNA–Bee
RNA isolation reagents (Tel-Test, Friendswood, TX). mRNAwas
then extracted with an Oligotex direct mRNA kit, following the
manufacturer's instructions (QIAGEN). For Northern blot
hybridization, 2 μg of mRNA from each sample was separated
in a 1% agarose gel containing 18% formaldehyde and
transferred to a nylon membrane, which was then hybridized
with 32P-radiolabeled KSHV-specific probes.
DNA array construction and probe hybridization
KSHV DNA array was constructed and hybridized similarly
to a previous description (Martinez-Guzman et al., 2003).
Briefly, primers were designed to amplify 200–500 bp regions
of cDNA sequence of known KSHV ORFs. Primers were
chosen to amplify a sequence from the human cellular GAPDH
(glyceraldehyde-3-phosphate dehydrogenase) gene that was
used as a positive control. The PCR products were confirmed by
agarose gel electrophoresis and were then ethanol precipitated
and resuspended in water at 100 ng/μl. Approximately 20 ng of
DNA was spotted in quadruplicate on Hybond-N membrane
(Amersham, Piscataway, N.J.) by using a replication system (V
and P Scientific, Inc. San Diego, CA). The DNA on the arrays
was denatured for 5 min (0.5 M NaOH, 1.5 M NaCl),
neutralized for 5 min (0.5 M Tris, 1.5 M NaCl), and UV
cross-linked to the membrane (Stratalinker). The quality of viral
DNA array elements was evaluated by the hybridization of 32P-
labeled KSHV-specific probes. 32P-labeled KSHV-specific
probes were generated from purified virion DNA using the
Amersham Rediprime™ II random prime labeling system (GEHealthcare). To determine the viral gene expression level,
RNA–Bee RNA isolation reagents (Tel-Test, Friendswood,
TX). Polyadenylated RNAwas then extracted with an Oligotex
direct mRNA kit, following the manufacturer's instructions
(QIAGEN). 500 ng polyadenylated RNA was used in each
reverse transcription (RT) reaction. The labeled cDNA probe
synthesis was prepared by using a Strip-EZ RT kit (Ambion,
Austin, TX) with [α-32P]dCTP (Perkin-Elmer). The labeled
probe was denatured at 100 °C. The prehybridization,
hybridization, and wash steps were carried out as previously
described (Lagunoff and Ganem, 1997).
Methyl thiazolyl tetrazolium (MTT) assay
Methyl thiazolyl tetrazolium (MTT) assay was done
according to manufacture's manual (Chemicon). Briefly, cells
were seeded into 96-well plates at a concentration of 1×104
cells per ml. At 0, 1, 2, 3, 4, and 5 days, cell proliferation was
evaluated using the MTT assay, in which 0.01 ml of MTT was
added to each well and then incubated at 37 °C for 4 h. At the
end of the assay, 0.1 ml color development solution was added
to each well to dissolve the blue formazan reaction product. The
absorbance was measured at 570 nm using a spectrophotometer.
The background absorbance produced by wells containing
medium only was subtracted from all wells. The results are
presented as the growth of each culture at each time point
relative to the initial number of cells that is presented on day 0.
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